AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
TT virus infection in end-stage renal disease (ESRD)
Authors: Fabrizi, F Martin, P Lunghi, G Locatelli, F
Citation: F. Fabrizi et al., TT virus infection in end-stage renal disease (ESRD), J NEPHROL, 14(2), 2001, pp. 80-87
Treatment of HBV-related liver disease in the dialysis population: realityand promises
Authors: Fabrizi, F Lunghi, G Martin, P
Citation: F. Fabrizi et al., Treatment of HBV-related liver disease in the dialysis population: realityand promises, INT J ARTIF, 24(9), 2001, pp. 598-605
Epidemiology of human immunodeficiency virus (HIV) infection in dialysis: recent insights
Authors: Fabrizi, F Lunghi, G Ponticelli, C
Citation: F. Fabrizi et al., Epidemiology of human immunodeficiency virus (HIV) infection in dialysis: recent insights, INT J ARTIF, 24(7), 2001, pp. 425-433
Treatment of HCV-related liver disease in the dialysis population: A novelchallenge for clinical nephrologists
Authors: Fabrizi, F Lunghi, G Martin, P
Citation: F. Fabrizi et al., Treatment of HCV-related liver disease in the dialysis population: A novelchallenge for clinical nephrologists, INT J ARTIF, 24(6), 2001, pp. 335-346
Hepatitis C virus infection in dialysis: an emerging clinical reality
Authors: Fabrizi, F Martin, P
Citation: F. Fabrizi et P. Martin, Hepatitis C virus infection in dialysis: an emerging clinical reality, INT J ARTIF, 24(3), 2001, pp. 123-130
Hepatitis B vaccine and dialysis: current issues
Authors: Fabrizi, F Martin, P
Citation: F. Fabrizi et P. Martin, Hepatitis B vaccine and dialysis: current issues, INT J ARTIF, 24(10), 2001, pp. 683-694
Novel evidence on hepatitis B virus infection in dialysis
Authors: Fabrizi, F Martin, P Lunghi, G Ponticelli, C
Citation: F. Fabrizi et al., Novel evidence on hepatitis B virus infection in dialysis, INT J ARTIF, 24(1), 2001, pp. 8-16
Hepatitis C virus infection and renal transplantation
Authors: Fabrizi, F Martin, P Ponticelli, C
Citation: F. Fabrizi et al., Hepatitis C virus infection and renal transplantation, AM J KIDNEY, 38(5), 2001, pp. 919-934
Decreased serum aminotransferase activity in patients with chronic renal failure: Impact on the detection of viral hepatitis
Authors: Fabrizi, F Lunghi, G Finazzi, S Colucci, P Pagano, A Ponticelli, C Locatelli, F
Citation: F. Fabrizi et al., Decreased serum aminotransferase activity in patients with chronic renal failure: Impact on the detection of viral hepatitis, AM J KIDNEY, 38(5), 2001, pp. 1009-1015
Automated RIBA (TM) HCV strip immunoblot assay: A novel tool for the diagnosis of hepatitis C virus infection in hemodialysis patients
Authors: Fabrizi, F Martin, P Dixit, V Quan, S Brezina, M Kaufman, E Sra, K Mousa, M DiNello, R Polito, A Gitnick, G
Citation: F. Fabrizi et al., Automated RIBA (TM) HCV strip immunoblot assay: A novel tool for the diagnosis of hepatitis C virus infection in hemodialysis patients, AM J NEPHR, 21(2), 2001, pp. 104-111
GBV-C/HGV infection in end-stage renal disease: a serological and virological survey
Authors: Fabrizi, F Lunghi, G Pozzi, C Colzani, S Tentori, F Del Vecchio, L Corti, M Pagano, A Locatelli, F
Citation: F. Fabrizi et al., GBV-C/HGV infection in end-stage renal disease: a serological and virological survey, J NEPHROL, 13(1), 2000, pp. 68-74
Membrane compatibility, flux and HCV infection in dialysis patients: newerevidence
Authors: Fabrizi, F Martin, P Lunghi, G Locatelli, F
Citation: F. Fabrizi et al., Membrane compatibility, flux and HCV infection in dialysis patients: newerevidence, INT J ARTIF, 23(5), 2000, pp. 296-304
Helicobacter pylori infection in patients with end-stage renal disease
Authors: Fabrizi, F Martin, P
Citation: F. Fabrizi et P. Martin, Helicobacter pylori infection in patients with end-stage renal disease, INT J ARTIF, 23(3), 2000, pp. 157-164
Nosocomial transmission of hepatitis C virus infection in hemodialysis patients: Clinical perspectives
Authors: Fabrizi, F Martin, P Lunghi, G Ponticelli, C
Citation: F. Fabrizi et al., Nosocomial transmission of hepatitis C virus infection in hemodialysis patients: Clinical perspectives, INT J ARTIF, 23(12), 2000, pp. 805-816
Liver disease in dialysis patients
Authors: Fabrizi, F Martin, P Lunghi, G Locatelli, F
Citation: F. Fabrizi et al., Liver disease in dialysis patients, INT J ARTIF, 23(11), 2000, pp. 736-749
Serotyping strip immunoblot assay for assessing hepatitis C virus strains in dialysis patients
Authors: Fabrizi, F Martin, P Quan, S Dixit, V Brezina, M Conrad, A Polito, A Gitnick, G
Citation: F. Fabrizi et al., Serotyping strip immunoblot assay for assessing hepatitis C virus strains in dialysis patients, AM J KIDNEY, 35(5), 2000, pp. 832-838
Biological dynamics of viral load in hemodialysis patients with hepatitis C virus
Authors: Fabrizi, F Martin, P Dixit, V Brezina, M Cole, MJ Vinson, S Mousa, M Gitnick, G
Citation: F. Fabrizi et al., Biological dynamics of viral load in hemodialysis patients with hepatitis C virus, AM J KIDNEY, 35(1), 2000, pp. 122-129
Hepatitis B virus infection in dialysis patients
Authors: Fabrizi, F Martin, P
Citation: F. Fabrizi et P. Martin, Hepatitis B virus infection in dialysis patients, AM J NEPHR, 20(1), 2000, pp. 1-11
Histopathological features of hepatitis C in renal transplant candidates
Authors: Martin, P Carter, D Fabrizi, F Dixit, V Conrad, AJ Artinian, L Peacock, V Han, S Wilkinson, A Lassman, CR Danovitch, G
Citation: P. Martin et al., Histopathological features of hepatitis C in renal transplant candidates, TRANSPLANT, 69(7), 2000, pp. 1479-1484
GBV-C/HGV infection in end-stage renal disease
Authors: Fabrizi, F Martin, P
Citation: F. Fabrizi et P. Martin, GBV-C/HGV infection in end-stage renal disease, J NEPHROL, 12(3), 1999, pp. 131-139
Antiphospholipid (aPL) antibodies in end-stage renal disease
Authors: Fabrizi, F Sangiorgio, R Pontoriero, G Corti, M Tentori, F Troina, E Locatelli, F
Citation: F. Fabrizi et al., Antiphospholipid (aPL) antibodies in end-stage renal disease, J NEPHROL, 12(2), 1999, pp. 89-94
Combination of interferon alpha and ribavirin in the treatment of hepatitis C: implications for the clinical nephrologist
Authors: Fabrizi, F Locatelli, F
Citation: F. Fabrizi et F. Locatelli, Combination of interferon alpha and ribavirin in the treatment of hepatitis C: implications for the clinical nephrologist, NEPH DIAL T, 14(9), 1999, pp. 2079-2081
Epidemiology of Helicobacter pylori in chronic haemodialysis patients using the new RIBA (TM) H-pylori SIA
Authors: Fabrizi, F Martin, P Dixit, V Quan, S Brezina, M Abbey, H Gerosa, S Kaufman, E DiNello, R Polito, A Gitnick, G
Citation: F. Fabrizi et al., Epidemiology of Helicobacter pylori in chronic haemodialysis patients using the new RIBA (TM) H-pylori SIA, NEPH DIAL T, 14(8), 1999, pp. 1929-1933
Hepatitis C virus in the haemodialysis units: novel insights by new techniques?
Authors: Fabrizi, F Locatelli, F
Citation: F. Fabrizi et F. Locatelli, Hepatitis C virus in the haemodialysis units: novel insights by new techniques?, NEPH DIAL T, 14(5), 1999, pp. 1072-1075
Hepatitis E virus in end-stage renal disease
Authors: Fabrizi, F Martin, P
Citation: F. Fabrizi et P. Martin, Hepatitis E virus in end-stage renal disease, INT J ARTIF, 22(9), 1999, pp. 593-599
Risultati: 1-25 | 26-28